Search

Your search keyword '"Gunaratnam, Cedric"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Gunaratnam, Cedric" Remove constraint Author: "Gunaratnam, Cedric"
139 results on '"Gunaratnam, Cedric"'

Search Results

1. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

2. An integrated multidisciplinary model of COVID-19 recovery care

5. Augmentation therapy for severe alpha-1 antitrypsin deficiency improves survival but is decoupled from FEV1 decline

6. Long-term follow-up of Pi*ZZ alpha-1 antitrypsin deficient patients receiving intravenous alpha-1 antitrypsin augmentation therapy

7. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline – A Multi-National Registry Analysis

13. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline--A Multinational Registry Analysis.

14. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

22. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

24. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

25. Altered Degranulation and pH of Neutrophil Phagosomes Impacts Antimicrobial Efficiency in Cystic Fibrosis

29. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

30. Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19)

31. Characterization of the Inflammatory Response to Severe COVID-19 Illness

32. An integrated multidisciplinary model of COVID-19 recovery care

34. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

40. Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of Ireland

41. An integrated multidisciplinary model of COVID-19 recovery care.

42. Clarifying the Risk of Lung Disease in SZ α-1 antitrypsin Deficiency: Online Data Supplement.

43. Specific Inhibition of the NLRP3 Inflammasome as an Anti-Inflammatory Strategy in Cystic Fibrosis.

45. Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung Disease

46. The Basophil Surface Marker CD203c Identifies Aspergillus Sensitization in 2 Cystic Fibrosis

47. Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).

48. Abstracts from the 5th International Conference for Healthcare and Medical Students (ICHAMS)

Catalog

Books, media, physical & digital resources